Last month, regulators in Australia and the U.K. signed off on the medicine. "Andembry, CSL's first approved recombinant monoclonal antibody discovered and developed entirely by CSL, underscores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback